In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
386 News Items found
scale
Q&A
Why Are More Young Adults Getting Cancer? Obesity May Be to Blame

Cancer among younger Americans is on the rise, and much of it is linked to obesity. An MSK expert on diet and cancer explains what’s behind this disturbing new trend.
Illustration of a magnifying glass and DNA sequences
Finding
Machine Learning May Help Classify Cancers of Unknown Primary

MSK investigators report a new tool that may help them determine the origin of some metastatic tumors, potentially leading to better targeted treatments.
Physician standing in front of a whiteboard
Finding
Novel Drug Advancing to Phase II Basket Trial of Solid Tumors

Learn more about entrectinib, a targeted therapy being evaluated in patients with solid tumors.
PhD candidate Laura Menocal wearing a mask in the lab
The Path Ahead: How MSK Responded to COVID-19

Learn how Memorial Sloan Kettering Cancer Center kept caring for patients during the response to COVID-19, and how lessons learned during the pandemic are helping cancer care.
A Hodgkin lymphoma survivor who received nivolumab as part of a clinical trial.
In the Clinic
Immunotherapy Drug Approved for Treatment of Hodgkin Lymphoma

The immunotherapy drug nivolumab is now approved for patients whose Hodgkin lymphoma has failed other treatments.
Fibrous extensions of a nerve cell (red) and an oligodendrocyte (green) growing on top of the nerve cell
In the Lab
Can Stem Cells Be Taught to Repair a Radiation-Damaged Brain?

In a recent study, Memorial Sloan Kettering scientists used stem-cell engineering to repair brain injuries in rats. The results raise hope for future therapies that could prevent or fix nerve damage in cancer patients who need brain radiation.
Pictured: Joan Massagué
Announcement
Cancer Biologist Joan Massagué Named Director of the Sloan Kettering Institute

Internationally recognized cancer biologist Joan Massagué has been named Director of the Sloan Kettering Institute. He was previously Chair of the Cancer Biology and Genetics Program at Memorial Sloan Kettering.
Cancer biologist and pediatric oncologist Alex Kentsis
Science Byte
Blocking Enzymes That Signal DNA Damage Could Be a Treatment Strategy for Childhood Cancers

A new strategy for treating pediatric cancers involves preventing cells from repairing their own DNA.
Gerstner Sloan Kettering Students
8 Gerstner Sloan Kettering Students Prepare To Graduate

Eight scientists are poised to receive their doctorates and embark on careers tackling problems in human disease through biomedical research. Their years of dedication and training will be recognized on May 18, 2022, when they will be awarded their PhD degrees from the Gerstner Sloan Kettering Graduate School of Biomedical Sciences (GSK). This year’s commencement marks the school’s 11th graduating class since admitting its first students in 2006.
Pictured: Ping Chi
Q&A
At Work: Physician-Scientist Ping Chi

Dr. Chi, a physician-scientist and member of the Human Oncology and Pathogenesis Program, studies genetic and epigenetic changes that cause cancer.